reference/32479298

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32479298

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	2033
issn	1535-7163 1538-8514
issueIdentifier	10
pageRange	2023-2033
publicationName	Molecular Cancer Therapeutics
startingPage	2023
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fd9ee57179a15116ed6a560a15d30afd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_21a30339bae3a924a4fae709a0a2f262 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0352fa9dbf5677f98c9a97bb83d9d515 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_19830b8230fcb297aaa97622669e0ab0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_af01e20ea819a4f2bb16159c7868869a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8a84060532d8b9418fd17a2962a3d068 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c2151b9f5a6f6895b47bdb33d6db7487 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_59067935ff67461719e9c0bf9948c5c9
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c1b20f0dd9567bf8b4b9be717437fa05 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_117a8e800e4d0819189c217001f31941 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_db5f5853f788fbd8e8ed857a2d8a5e2a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5e46fbb513b66889878a7bedabd45a7f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b9f7ead86e38c125d25e4e900d4ced79 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e6f0adfa328399cc69373e6ec31fd828
bibliographicCitation	Li Q, Liu KY, Liu Q, Wang G, Jiang W, Meng Q, Yi Y, Yang Y, Wang R, Zhu S, Li C, Wu L, Zhao D, Yan L, Zhang L, Kim JS, Zu X, Kozielski AJ, Qian W, Chang JC, Patnaik A, Chen K, Cao Q. Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2. Mol Cancer Ther. 2020 Oct;19(10):2023–33. PMID: 32855270; PMCID: PMC7541747.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29b92c411467f173aafa629f80981984 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d871c091f635d58f2e5172330a1c647e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_229b189a26813b8c2bc3c8b67d4e0d23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_742bff10111f76e6a04b3ef019fb6ef8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c51f2fe5f0d4de77542d35c9455788ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa652d6c3cef01ba14a88075e4adce55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5eaaad188dcc1c8fad124dbfa6fb6e74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c178cfd1cd088a33da21de778e8ab3b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f4d77e7eee154f18aff96fdf6ea1182 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8ee3ccc29dbcc819043df44729979d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1009-4357 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3d6702b36a6b147b05ab2ba5651ce7e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b48182ce7c52db39f4224bb6d49585f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f917f656a60893b3fde17b5938a40414 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02d1763db8417164c9fcec43aad17da3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_284519ef8bbc234ce84cbc9902b87c0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68888d4e68f84d921b3457b1d39d6835 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af2fc74d76796f7b6b5ade9e259a03dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_006fd48d6613dcd8b575200f02e1ff4d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf7ef1818e49748b7ce1e78502a3e05c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e88749a4e11a6f96c050ec3600e684f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5140-3681 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f369f79ada71f70c5177a5f20b41cae http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4803-7200
date	2020-10-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1535-7163.mct-20-0250 https://pubmed.ncbi.nlm.nih.gov/PMC7541747 https://pubmed.ncbi.nlm.nih.gov/32855270
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097 https://portal.issn.org/resource/ISSN/1538-8514 https://portal.issn.org/resource/ISSN/1535-7163
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2
discusses	http://id.nlm.nih.gov/mesh/M0003113 http://id.nlm.nih.gov/mesh/M000613664 http://id.nlm.nih.gov/mesh/M0442870 http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0162527 http://id.nlm.nih.gov/mesh/M0010395
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000071221Q000187 http://id.nlm.nih.gov/mesh/D002090Q000627 http://id.nlm.nih.gov/mesh/D010880Q000627 http://id.nlm.nih.gov/mesh/D006634Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010880Q000494 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006634Q000494 http://id.nlm.nih.gov/mesh/D002090Q000494
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3191 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68210102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c3addd02e769f33d86f94bb13502ccd5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2146

Showing number of triples: 1 to 86 of 86.